Table 2. Access to and actualization of gender-affirming resources among self-identified transgender and nonbinary individuals from the COVID disparities working group survey between April 16 and August 3, 2020 (N = 964).
| Overall (%) | Transmasculine | Transfeminine | Nonbinary | p-valueb | |
|---|---|---|---|---|---|
| Experienced reduced access to one or more gender-affirming resource belowa | 320 / 582 (55.0%) | 17 / 26 (65.4%) | 110 / 189 (58.2%) | 193 / 367 (52.6%) | 0.25 |
| Hormone therapy and/or gender-affirming medication | 143 / 401 (35.7%) | 11 / 20 (55.0%) | 61 / 145 (42.1%) | 71 / 236 (30.1%) | 0.01 |
| Surgical aftercare | 119 / 356 (33.4%) | 6 / 14 (42.9%) | 51 / 127 (40.2%) | 62 / 215 (28.8%) | 0.08 |
| Cosmetic supplies and services, e.g., makeup, wigs, and hair removal | 189 / 500 (37.8%) | 9 / 21 (42.9%) | 65 / 162 (40.1%) | 115 / 317 (36.3%) | 0.63 |
| Mental health counseling and therapy* | 192 / 448 (42.9%) | 13 / 21 (61.9%) | 57 / 143 (39.9%) | 122 / 284 (43.0%) | 0.16 |
| Body modifiers, e.g., binders and packing material | 160 / 443 (36.1%) | 8 / 18 (44.4%) | 57 / 148 (38.5%) | 95 / 277 (34.3%) | 0.52 |
| Compared to before the COVID-19 pandemic, how often able to live according to their gender | |||||
| More or a lot more | 67 / 860 (7.8%) | 7 / 28 (25.0%) | 22 / 232 (9.5%) | 38 / 600 (7.1%) | < 0.001 |
| About the same | 466 (54.2%) | 13 (46.4%) | 110 (47.4%) | 343 (57.2%) | |
| Less or not at all | 327 (38.0%) | 8 (28.6%) | 100 (43.1%) | 219 (36.5%) |
a Denominators excluded participants who were not presented with these questions, did not respond, or said that the resource was not applicable to them.
b p-values were calculated using chi-squared and Fischer’s exact tests as appropriate